Suppr超能文献

血液透析患者肺动脉高压的促成因素

Contributing Factors of Pulmonary Hypertension in Hemodialysis Patients.

作者信息

Behzadnia Neda, Esmaeilinejad Komeil, Rashid-Farokhi Farin, Pourdowlat Guitti

机构信息

Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Chronic Respiratory Disease Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Tanaffos. 2023 Apr;22(4):375-381.

Abstract

BACKGROUND

Pulmonary hypertension (PH) is a known complication of hemodialysis (HD) but its pathogenesis and etiology is not completely clear. The purpose of the current study is to determine the prevalence and possible causes of PH among hemodialysis patients.

MATERIAL AND METHODS

Demographic, clinical and laboratory data of 40 patients referred to hemodialysis ward of Masih Daneshvari Hospital during 12 months were recorded. Detailed echocardiography was performed for each patient within 24 hours of hemodialysis. PH was defined as systolic pulmonary artery pressure (SPAP) above 35 mmHg.

RESULTS

12 of 40 HD patients had PH (prevalence = 30%). The hemodialysis vintage in PH group was longer than patients without PH (No PH group) . Also, left atrium size, right ventricle size, left ventricle end diastolic diameter (LVEDD) and left ventricular mass index (LV mass index) were significantly higher in PH group; but ejection fraction (EF) was lower than No PH group. Left ventricle diastolic dysfunction and pericardial effusion were significantly associated with PH. The crude mortality rate was relatively similar in PH group and No PH group.

CONCLUSION

PH is prevalent in HD patients with multifactorial etiology. Increased pulmonary capillary wedge pressure (PCWP) is a very important factor to induce PH in these patients; on the other hand, chronic volume overload and left ventricle systolic and diastolic dysfunction are some of the predominant causes of increased PCWP in this population.

摘要

背景

肺动脉高压(PH)是血液透析(HD)已知的并发症,但其发病机制和病因尚不完全清楚。本研究的目的是确定血液透析患者中PH的患病率及可能病因。

材料与方法

记录了12个月内转诊至马西·达内什瓦里医院血液透析病房的40例患者的人口统计学、临床和实验室数据。在血液透析24小时内对每位患者进行详细的超声心动图检查。PH定义为收缩期肺动脉压(SPAP)高于35 mmHg。

结果

40例HD患者中有12例患有PH(患病率 = 30%)。PH组的血液透析病程长于无PH患者(非PH组)。此外,PH组的左心房大小、右心室大小、左心室舒张末期直径(LVEDD)和左心室质量指数(LV质量指数)显著更高;但射血分数(EF)低于非PH组。左心室舒张功能障碍和心包积液与PH显著相关。PH组和非PH组的粗死亡率相对相似。

结论

PH在病因多因素的HD患者中普遍存在。肺毛细血管楔压(PCWP)升高是这些患者诱发PH的一个非常重要的因素;另一方面,慢性容量超负荷以及左心室收缩和舒张功能障碍是该人群中PCWP升高的一些主要原因。

相似文献

本文引用的文献

2
Pulmonary hypertension in dialysis patients.透析患者的肺动脉高压。
Ren Fail. 2013;35(4):514-20. doi: 10.3109/0886022X.2013.766559. Epub 2013 Feb 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验